Geistlich Pharma AG researches, manufactures and provides pharmaceutical products, gelatine products, biomaterials and industrial glues. It offers Geistlich Bio-Oss and Geistlich Bio-Gide products. The firm specializes in biomaterials for the regeneration of bone, cartilage and tissue and develops, and manufactures medical devices. The company was founded in 1851 and is headquartered in Wolhusen, Switzerland.

CorMatrix Cardiovascular is a privately held medical device company that is dedicated to developing and delivering innovative biomaterial devices that harness the body’s own innate ability to repair damaged heart tissue. The company is currently researching, developing, and commercializing a platform technology, known as CorMatrix ECM, for a variety of cardiovascular indications. Incorporated in December of 2001, CorMatrix was co-founded by David Camp, an entrepreneurial executive in the cardiovascular medical device field, and Robert G. Matheny, MD, a cardiothoracic surgeon and co-inventor on several patents related to extracellular matrix (ECM) technology. Dr. Matheny’s interest and experience with these unique materials began at Purdue University in the 1990s while he was a private practice cardiac surgeon in Indianapolis. Realizing the potential of extracellular matrix materials for cardiovascular surgery, he further increased his study and preclinical work in matrix materials and tissue repair.

Yantai Zhenghai Biological Technology is a platform for the development of regenerative medical materials, such as a lab for material engineering. Oral repair membrane, absorbable dura membrane patch, biological bone, skin repair membrane, bone repair substance, surgical tamponade sponge, and self-etching adhesive are among the products listed. Clinically, it aids doctors and patients in the fields of stomatology, head and neck surgery, neurosurgery, ENT, and others.

Part of Medtronic Plc, Warsaw Orthopedic, Inc. is a company headquartered in the United States that operates orthopedic center.

Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The company’s core technology is a iodegradable hydrogel called Gelrin™. It is based on polyethylene glycol diacrylate and denatured fibrinogen originally developed at the Technion University by Dr. Dror Seliktar. The Gelrin hydrogel platform combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications and has undergone extensive preclinical and safety testing over the last few years. The company’s flagship product, GelrinC™,designed for the treatment of articular cartilage lesions, is currently in clinical trials.

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which is a naturally derived collagen medical device for soft tissue repair, and Antilogous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

Jiangsu Dubu Biotechnology Co., Ltd., established on 2021-01-19, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Drug Wholesale;Drug retail;Inspection and testing service;Import and export agency;Import and export;Technology Import and Export;Food additive production;Health food production;Production of hygiene products and single-use medical products;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Experimental analysis instrument sales;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;New material technology research and development;Food Additive Sales;Retailing of Edible Agricultural Products;Cosmetics Retail;Personal Hygiene Sales;Sales of hygiene products and single-use medical products;Chemical product sales(No licensed chemical products);Information Consulting Service(Not including licensing information consulting services);Conference and Exhibition Services;R&D and application of cell technology;Medical Research and Experimental Development;Manufacturing of daily necessities;HR Services(Excludes job brokerage activities,Labor dispatch service);Labor service(Does not include labor dispatch);Business agency service;Personal Business Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pegasus Biologics, Inc. engages in manufacturing, developing, and marketing bioimplants for soft tissue repair and wound care for diabetic ulcers. Its products include OrthADAPT Bioimplant, which is an organized tissue scaffold that used for the repair and reinforcement of soft tissues, such as tendons and ligaments; and Unite Biomatrix, which is an enzyme resistant collagen scaffold that allows for suture retention and intrinsic strength. The company serves orthopedics, sports medicine, neurosurgical, and spine applications. Pegasus Biologics, Inc. was founded in 2003 and is based in Irvine, California. As of July 17, 2009, Pegasus Biologics, Inc. operates as a subsidiary of Synovis Life Technologies Inc.

Regeneration Technologies, Inc. (RTI) is engaged in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. RTI's patented BioCleanse® tissue sterilization process is validated to eliminate bacteria, fungi, spores and viruses from the tissue. The company is located in Alachua, FL.

Bonag Technology (Tianjin) Co., Ltd., established on 2018-10-17, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;New material technology research and development;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of Class I Medical Devices;Production of Class I Medical Devices;Cosmetics Retail;Cosmetics Wholesale;Sales of Class II Medical Devices;Domestic trade agent.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Cosmetic production;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shanghai Hongchuang Medical Technology Co., Ltd., established on 2014-04-10, Business scope includes licensed projects:Production of Class III Medical Devices;Production of Class II Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technology development in the field of medical technology,technology transfer,technical consulting,Technical Services,Production of Class I Medical Devices,First,Class II medical device sales,Own Equipment Rental,business inquiries,Business Management Consulting,account Serive,Import and export,Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Hengruidisheng Medical Technology Co., Ltd., established on 2015-11-12, Business scope includes research and development,Production,Sales:Various medical equipment;Engage in technology development in the field of medical device technology,technology transfer,technical consulting,Technical Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Zhongke Zaikang Biotechnology Co., Ltd., established on 2017-11-03, Business scope includes technology development,Technical Services,technical consulting,technology transfer;Technology Import and Export;Natural science research and experimental development;Technical testing service;Agent import and export;Import and export;Sales of Class I medical devices,Class II medical device,cosmetic;Information Technology Consulting Services;Business agency service;Sales of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Synovis Life Technologies, Inc. manufactures medical devices. It markets biological and mechanical products used by surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company was founded in July 1985 and is headquartered in St. Paul, MN.

Acen Med is a biomedical research and advanced cell engineering firm. Their products include stem cell preparations, 3D printed stem cell products, stem cell extracts, immune cell preparations, serum-free medium, cell bioreactors, and cell storage.

TEI Biosciences, Inc. develops and distributes novel biologic products for soft tissue repair, reinforcement and reconstruction applications. Its products include SurgiMend 1.0-4.0, SurgiMend-e, SurgiMend PRS, PriMatrix, PriMatrix AG, Durepair, TissueMend and Xenform. The firm’s products are used in general surgery, plastic and reconstructive surgery, trauma, wound care and burns, neurosurgery, orthopedics and urogynecology. The company was founded in 1993 and is headquartered in Waltham, MA.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.